According to Rocket Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$3.31. In 2022 the company made an earnings per share (EPS) of -$3.26 a decrease over its 2021 EPS that were of -$2.68.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.31 | 1.53% |
2022 | -$3.26 | 21.64% |
2021 | -$2.68 | 6.35% |
2020 | -$2.52 | 59.49% |
2019 | -$1.58 | -16.4% |
2018 | -$1.89 | -56.35% |
2017 | -$4.33 | -32.45% |
2016 | -$6.41 | -40.87% |
2015 | -$10.84 | 117.09% |
2014 | -$4.99 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -34.14% | ๐บ๐ธ USA |